ロード中...
Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
Type 2 diabetes (T2D) is a progressive disease affecting glucose regulation and a major cause of morbidity and mortality globally. Many patients are not escalated up the treatment ladder appropriately despite failing to achieve glycemic control, with barriers such as fear of hypoglycemia, weight gai...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5544623/ https://ncbi.nlm.nih.gov/pubmed/28721686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0287-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|